Amplification of the human epidermal growth factor receptor 2 (HER2)/neu (ERBB2) gene and overexpression of the oncoprotein HER2 occur in around 20% of breast cancers, termed “HER2-positive (HER2+) breast cancer” [1–3]. The gene discussed is ERBB2; the disease is breast carcinoma.